Prospective study of live attenuated vaccines for patients with nephrotic syndrome receiving immunosuppressive agents
The Journal of Pediatrics Mar 06, 2018
Kamei K, et al. - An inquiry was set up regarding the immunogenicity and safety of live attenuated vaccines in patients with nephrotic syndrome receiving immunosuppressive agents. It was reported that immunization with live attenuated vaccines could be immunogenic. It was discovered to be safe in individuals with nephrotic syndrome receiving immunosuppressive agents if their cellular and humoral immunologic measures were within clinically acceptable levels.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries